Analysis of prostate cancer using serum surface-enhanced Raman spectroscopy and multivariate statistical algorithm

Xin Zhao; Jiamin Gao; Yamin Lin; Xin Bai; Zeqin Hu; Xiang Wu; Tao Li; Yun Yu; Juqiang Lin

doi:10.1117/12.2656204

26 October 2022 Analysis of prostate cancer using serum surface-enhanced Raman spectroscopy and multivariate statistical algorithm

Xin Zhao, Jiamin Gao, Yamin Lin, Xin Bai, Zeqin Hu, Xiang Wu, Tao Li, Yun Yu, Juqiang Lin

Author Affiliations +

Proceedings Volume 12461, First Conference on Biomedical Photonics and Cross-Fusion (BPC 2022); 1246104 (2022) https://doi.org/10.1117/12.2656204
Event: First Conference on Biomedical Photonics and Cross-Fusion (BPC 2022), 2022, Shanghai, China

Abstract

Prostate cancer (PCa) is an epithelial malignant tumor occurring in the prostate gland and is the most common malignancy of the male genitourinary system. Prostate cancer is often asymptomatic in its early stage, and the best treatment time is usually missed when it is found. Therefore, early diagnosis and treatment is the key to reduce the mortality of prostate cancer patients. In this work, we developed a method to identify patients with prostate cancer and healthy volunteers. We collected serum samples from patients with prostate cancer and healthy volunteers, detected the SERS spectra of these serum samples, and analyzed the SERS spectrum of the obtained serum samples with a preliminary spectral peak assignment. Then principal component analysis (PCA) combined with linear discriminant analysis (LDA) was used to diagnose the SERS spectra of serum from patients with prostate cancer and healthy volunteers. Difference spectrum analysis showed that there are obvious differences in several characteristic peaks between the serum of patients with prostate cancer and the serum of healthy volunteers, which may be related to the special changes of nucleic acids, proteins, lipids and other biological molecules in the process of carcinogenesis. Using principal component analysis (PCA) combined with linear discriminant analysis (LDA) multivariate statistical method, the diagnostic sensitivity and specificity were 85% and 95%, respectively. The receiver operating characteristic (ROC) curve further proves the effectiveness of diagnosis algorithm based on PCA-LDA technology, and the area under the curve (AUC) is 0.998. These results show that the combination of SERS technology and PCA-LDA algorithm has great potential in screening prostate cancer patients.

Citation Download Citation

Xin Zhao, Jiamin Gao, Yamin Lin, Xin Bai, Zeqin Hu, Xiang Wu, Tao Li, Yun Yu, and Juqiang Lin "Analysis of prostate cancer using serum surface-enhanced Raman spectroscopy and multivariate statistical algorithm", Proc. SPIE 12461, First Conference on Biomedical Photonics and Cross-Fusion (BPC 2022), 1246104 (26 October 2022); https://doi.org/10.1117/12.2656204

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
7 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Prostate cancer

Surface enhanced Raman spectroscopy

Raman spectroscopy

Principal component analysis

Statistical analysis

Diagnostics

Prostate

Show All Keywords

Keywords/Phrases

Search In:

Publication Years